- Page 2:
ILLUSTRATED DICTIONARY OF IMMUNOLOG
- Page 5 and 6:
CRC Press Taylor & Francis Group 60
- Page 8:
Preface The splendid reception of t
- Page 12 and 13:
Illustration Credits Figure for C1
- Page 14:
Figure for Sustiva ® (efavirenz ca
- Page 17 and 18:
α helix 2 αβ TCR checkpoint muco
- Page 19 and 20:
abzyme 4 accessory molecules Trypan
- Page 21 and 22:
acetaldehyde adduct autoantibodies
- Page 23 and 24:
acquired immunity 8 activated lymph
- Page 25 and 26:
acute cellular rejection 10 acute d
- Page 27 and 28:
acute graft-vs.-host reaction 12 ac
- Page 29 and 30:
acute lymphoblastic leukemia (ALL)
- Page 31 and 32:
acute poststreptococcal glomerulone
- Page 33 and 34:
acyclic adenosine monophosphate (cA
- Page 35 and 36:
adhesion receptors 20 adjuvant ICAM
- Page 37 and 38:
adoptive immunization 22 adoptive t
- Page 39 and 40:
afferent lymphatic vessels 24 agar
- Page 41 and 42:
agretope 26 AIDS belt exposure to c
- Page 43 and 44:
airway hyper-responsiveness 28 alka
- Page 45 and 46:
allergic contact dermatitis 30 allo
- Page 47 and 48:
allophonic mouse 32 allotype suppre
- Page 49 and 50:
alternative complement pathway 34 a
- Page 51 and 52:
ALVAC 36 aminoethylcarbazole (AEC)
- Page 53 and 54:
amphiregulin 38 amyloid P component
- Page 55 and 56:
anaphylactoid reaction 40 anaphylax
- Page 57 and 58:
aneuploidy 42 angioimmunoblastic ly
- Page 59 and 60:
ankylosing spondylitis 44 antibodie
- Page 61 and 62:
antibody-dependent cell-mediated cy
- Page 63 and 64:
antibody unit 48 anti-CD5 monoclona
- Page 65 and 66:
anti-Clq antibody 50 anti-double-st
- Page 67 and 68:
antigen-binding site 52 antigen pre
- Page 69 and 70:
antigen-presenting cell (APC) 54 an
- Page 71 and 72:
antigenic gain 56 antigenic peptide
- Page 73 and 74:
antiglial fibrillary acidic protein
- Page 75 and 76:
anti-human cytokeratin 7 antibody 6
- Page 77 and 78:
anti-human prostatic acid phosphata
- Page 79 and 80:
antimuscle actin primary antibody 6
- Page 81 and 82:
antinucleosome antibodies 66 antipa
- Page 83 and 84:
antiprogesterone receptor antibody
- Page 85 and 86:
antithymocyte globulin (ATG) 70 AP-
- Page 87 and 88:
apoptosis 72 apoptosis Four caspase
- Page 89 and 90:
apoptosis, caspase pathway 74 apopt
- Page 91 and 92:
apoptosis, positive induction 76 ar
- Page 93 and 94:
Arthus reaction 78 artificially acq
- Page 95 and 96:
aspirin sensitivity reaction 80 ath
- Page 97 and 98:
Auer rods 82 autoantibodies, virus
- Page 99 and 100:
autochthonous 84 autogenous vaccine
- Page 101 and 102:
autoimmune complement fixation reac
- Page 103 and 104:
autoimmune uveoretinitis 88 avian i
- Page 105 and 106:
avidity hypothesis 90 AZT Percent A
- Page 107 and 108:
B7.2 costimulatory molecule 92 B ce
- Page 109 and 110:
B cell coreceptor 94 B cell lymphop
- Page 111 and 112:
B lymphocyte antigen receptor (BCR)
- Page 113 and 114:
ackcross 98 bacterial immunity Euka
- Page 115 and 116:
actericidin 100 BALB/c mice bacteri
- Page 117 and 118:
asophil 102 Bcl-2 family A peripher
- Page 119 and 120:
enign 104 bentonite (Al 2O 3·4SiO
- Page 121 and 122:
β 1H 106 bifunctional antibodies
- Page 123 and 124:
iotin-avidin system 108 bispecific
- Page 125 and 126:
lood group antigens 110 BLR-1/MDR-1
- Page 127 and 128:
ooster phenomenon 112 botulinum tox
- Page 129 and 130:
equinar sodium (BQR) 114 Bretscher-
- Page 131 and 132:
Brucella vaccine 116 bullous pemphi
- Page 133 and 134:
ursa of Fabricius 118 butterfly ras
- Page 136 and 137:
c allotype A rabbit immunoglobulin
- Page 138 and 139:
C1q deficiency 123 C2 and B genes C
- Page 140 and 141:
C3 nephritic factor (C3NeF) 125 C3d
- Page 142 and 143:
C4d 127 C6 deficiency Immunofluores
- Page 144 and 145:
C9 deficiency 129 calcineurin above
- Page 146 and 147:
Calmette, Albert (1863-1933) 131 Ca
- Page 148 and 149:
caprinized vaccine 133 carbohydrate
- Page 150 and 151:
cardiolipin 135 cartilaginous fish
- Page 152 and 153:
Castleman’s disease 137 catalytic
- Page 154 and 155:
CD1a 139 CD3 α C1 COOH β m shown
- Page 156 and 157:
CD4 molecule 141 CD8 CD4 molecule E
- Page 158 and 159:
CD15 (Leu M1) 143 CD20 primary anti
- Page 160 and 161:
CD23(1B12) 145 CD32 stronger staini
- Page 162 and 163:
CD42c 147 CD45RO 170 kDa. CD42b has
- Page 164 and 165:
CD56 149 CD71 CD56 A 220/135-kDa mo
- Page 166 and 167:
CD93 151 CDw116 CD93 A 120-kDa anti
- Page 168 and 169:
CDw149 (redesignated CD47R) 153 CD1
- Page 170 and 171:
CD236R 155 CD278 CD236R A 32-kDa an
- Page 172 and 173:
CD314 157 CD350 CD314 A 42-kDa anti
- Page 174 and 175:
cell-bound antibody (cell-fixed ant
- Page 176 and 177:
cellular hypersensitivity 161 c-erb
- Page 178 and 179:
chemokine β receptor-like 1 163 ch
- Page 180 and 181:
chemotactic peptide 165 Chido (Ch)
- Page 182 and 183:
cholera vaccine 167 chromogranin mo
- Page 184 and 185:
chronic and cyclic neutropenia 169
- Page 186 and 187:
chronic lymphocytic leukemia 171 ch
- Page 188 and 189:
circulating anticoagulant 173 Clado
- Page 190 and 191:
class I region 175 class II MHC mol
- Page 192 and 193:
classical C3 convertase 177 classic
- Page 194 and 195:
clonal selection theory 179 Clostri
- Page 196 and 197:
cobra venom factor (CVF) 181 coelom
- Page 198 and 199:
collagen (type I, II, and III) auto
- Page 200 and 201:
combination vaccine 185 common lymp
- Page 202 and 203:
complement activation 187 complemen
- Page 204 and 205:
complement membrane attack complex
- Page 206 and 207:
concanavalin A (con A) 191 congenic
- Page 208 and 209:
consensus sequence 193 contact sens
- Page 210 and 211:
control tolerance 195 Coons, Albert
- Page 212 and 213:
corneal transplantation 197 cortico
- Page 214 and 215:
cowpox 199 C-reactive protein (CRP)
- Page 216 and 217:
cromolyn 201 cross tolerance cromol
- Page 218 and 219:
cryptodeterminant 203 cutaneous ana
- Page 220 and 221:
cyclooxygenase pathway 205 cyclospo
- Page 222 and 223:
CYNAP phenomenon 207 cytokeratin (3
- Page 224 and 225:
cytokine assays 209 cytokine-specif
- Page 226 and 227:
cytopathic effect (of viruses) 211
- Page 228:
cytotoxicity tests 213 cytotropic a
- Page 231 and 232:
Dameshek, William (1900-1969) 216 d
- Page 233 and 234:
decomplementation 218 degranulation
- Page 235 and 236:
delayed xenograft rejection 220 den
- Page 237 and 238:
density gradient centrifugation 222
- Page 239 and 240:
designer lymphocytes 224 desotope T
- Page 241 and 242:
dhobi itch 226 diathelic immunizati
- Page 243 and 244:
differentiation antigen 228 Dimsdal
- Page 245 and 246:
diphtheria toxoid 230 direct tag as
- Page 247 and 248:
diversity 232 DNA laddering Formati
- Page 249 and 250:
Doherty, Peter (1940-) 234 dot DAT
- Page 251 and 252:
doubling dilution 236 drug-induced
- Page 253 and 254:
dye exclusion test 238 dysgammaglob
- Page 255 and 256:
EAE 240 Echinococcus immunity and c
- Page 257 and 258:
Edelman, Gerald Maurice (1929-) 242
- Page 259 and 260:
EIA 244 Elek plate e a e I d b a c
- Page 261 and 262:
ENA autoantibodies 246 endocytosis
- Page 263 and 264:
endoplasmic reticulum autoantibodie
- Page 265 and 266:
enzyme immunoassay (EIA) 250 eosino
- Page 267 and 268:
eotaxin-1 and eotaxin-2 252 epithel
- Page 269 and 270:
equilibrium constant 254 erythema n
- Page 271 and 272:
etanercept (injection) 256 exon for
- Page 273 and 274:
experimental autoimmune sialoadenit
- Page 276 and 277:
F-actin Actin molecules in a dual-s
- Page 278 and 279:
factor H deficiency 263 Faenia rect
- Page 280 and 281:
Farr technique 265 Fasciola immunit
- Page 282 and 283:
FcμR 267 Fc receptors on human T c
- Page 284 and 285:
Fcγ R 269 feline immunity Fc R The
- Page 286 and 287:
Feulgen reaction 271 fibrin villous
- Page 288 and 289:
filariasis 273 fish immunity filari
- Page 290 and 291:
flame cells 275 FLIP/FLAM 95 40 78
- Page 292 and 293:
Flt3 ligand 277 fluorescein isothio
- Page 294 and 295:
fluorescence treponemal antibody te
- Page 296 and 297:
follicular lymphoma 281 foscarnet i
- Page 298 and 299:
freemartin 283 functional affinity
- Page 300:
fusin 285 fyn fusin A receptor pres
- Page 303 and 304:
γδ T cells 288 gastric cell cAMP-
- Page 305 and 306:
gene amplification 290 gene escape
- Page 307 and 308:
genetic polymorphism 292 genotype D
- Page 309 and 310:
Ghon complex 294 globulin Richard K
- Page 311 and 312:
glucocorticoids (GCs) 296 Gm alloty
- Page 313 and 314:
Golgi apparatus 298 Goodpasture’s
- Page 315 and 316:
gp41 300 graft changed the understa
- Page 317 and 318:
graft-vs.-leukemia (GVL) 302 granul
- Page 319 and 320:
granulomatous hepatitis 304 Guillai
- Page 322 and 323:
H-2 complex Murine major histocompa
- Page 324 and 325:
HALV (human AIDS-lymphotrophic viru
- Page 326 and 327:
Hassall’s corpuscles 311 HAT medi
- Page 328 and 329:
HCC-1 313 heavy chain diseases In t
- Page 330 and 331:
helminth 315 hematopoiesis thereby
- Page 332 and 333:
hemolysis 317 hemolytic plaque assa
- Page 334 and 335:
hepatitis A, inactivated and hepati
- Page 336 and 337:
hepatitis serology 321 herpes gesta
- Page 338 and 339:
herpesvirus-8 immunity 323 heteroph
- Page 340 and 341:
high endothelial postcapillary venu
- Page 342 and 343:
histamine-releasing factor 327 hist
- Page 344 and 345:
histoplasmin 329 HIV-1 genes G-O HL
- Page 346 and 347:
HIV infection 331 HLA Nuclear magne
- Page 348 and 349:
HLA allelic variation 333 HLA class
- Page 350 and 351:
HLA-DP subregion 335 HLA-DR antigen
- Page 352 and 353:
HLA type 337 homing Wells for diffe
- Page 354 and 355:
homologous recombination pathway 33
- Page 356 and 357:
HSC mobilization 341 (quadrivalent,
- Page 358 and 359:
HUT 78 343 hybrid resistance Baseme
- Page 360 and 361:
hyperacute xenograft rejection 345
- Page 362 and 363:
hypersensitivity angiitis 347 hypog
- Page 364 and 365:
I-309 A chemokine of the β (CC) fa
- Page 366 and 367:
idiotype suppression 351 Igα and I
- Page 368 and 369:
IgM 353 IL4 have recurrent respirat
- Page 370 and 371:
immediate spin cross match 355 immu
- Page 372 and 373:
immune exclusion 357 immune-neuroen
- Page 374 and 375:
immune response (Ir) genes 359 immu
- Page 376 and 377:
immunoblast 361 immunocytoadherence
- Page 378 and 379:
immunodeficiency associated with he
- Page 380 and 381:
immunoenhancement 365 immunofluores
- Page 382 and 383:
immunoglobulin A (IgA) 367 immunogl
- Page 384 and 385:
immunoglobulin δ chain 369 immunog
- Page 386 and 387:
immunoglobulin G (IgG) 371 immunogl
- Page 388 and 389:
immunoglobulin M (IgM) 373 immunogl
- Page 390 and 391:
immunoglobulin monomer 375 immunogl
- Page 392 and 393: immunoglobulin structure 377 immuno
- Page 394 and 395: immunologic facilitation (facilitat
- Page 396 and 397: immunologist 381 immunophenotyping
- Page 398 and 399: immunoprophylaxis 383 immunoregulat
- Page 400 and 401: immunotactoid glomerulopathy 385 in
- Page 402 and 403: indirect tag assays 387 infectious
- Page 404 and 405: inflammatory myopathy 389 influenza
- Page 406 and 407: influenza virus vaccine 391 innate
- Page 408 and 409: instructive theory of antibody form
- Page 410 and 411: interallelic conversion 395 intercr
- Page 412 and 413: interferon γ-1b (injection) 397 in
- Page 414 and 415: interleukin-1 receptor antagonist p
- Page 416 and 417: interleukin-2 receptor α subunit (
- Page 418 and 419: interleukin-5 (IL5; eosinophil diff
- Page 420 and 421: interleukin-6 receptor 405 interleu
- Page 422 and 423: interleukin-8 receptor, type A (IL8
- Page 424 and 425: interleukin-11 receptor (IL11R) 409
- Page 426 and 427: interleukin-15 (IL15) 411 interleuk
- Page 428 and 429: interleukin-20 (IL20) 413 interleuk
- Page 430 and 431: interleukin-33 (IL33) 415 intracell
- Page 432 and 433: invariant (Ii) chain 417 invariant
- Page 434 and 435: iridovirus immunity 419 islet cell
- Page 436 and 437: isoelectric point (pI) 421 isotypes
- Page 438 and 439: Disulfide bonds β pleated sheets C
- Page 440 and 441: Jerne network theory 425 Jo-1 syndr
- Page 444 and 445: K antigens Surface epitopes of Gram
- Page 446 and 447: Kell blood group system 431 Ki auto
- Page 448 and 449: kininases 433 Klebsiella immunity R
- Page 450 and 451: Ku 435 Kunkel, Henry George (1916-1
- Page 452 and 453: L + dose (historical) The smallest
- Page 454 and 455: LAMP 1 and LAMP 2 439 Landsteiner,
- Page 456 and 457: lapinized vaccine 441 latex particl
- Page 458 and 459: lck, fyn, ZAP (phosphotyrosine kina
- Page 460 and 461: lepromatous leprosy 445 leukapheres
- Page 462 and 463: leukoagglutinin 447 leukocyte commo
- Page 464 and 465: leukocytosis 449 leukotriene Leukoc
- Page 466 and 467: Lewis blood group system 451 light
- Page 468 and 469: light zone 453 linkage disequilibri
- Page 470 and 471: linked recognition 455 linked recog
- Page 472 and 473: Listeria monocytogenes 457 liver-ki
- Page 474 and 475: long homologous repeat 459 LPS Stim
- Page 476 and 477: lupus inhibitor 461 lymphadenopathy
- Page 478 and 479: lymphoblast 463 lymphocyte Subcapsu
- Page 480 and 481: lymphocyte antigen stimulation test
- Page 482 and 483: lymphocytes, circulating (or recirc
- Page 484 and 485: lymphokine 469 lysis Fabricius in b
- Page 486 and 487: M13 bacteriophage An Escherichia co
- Page 488 and 489: macrophage-activating factor (MAF)
- Page 490 and 491: macrophage inflammatory protein 1β
- Page 492 and 493:
MAF 477 major histocompatibility co
- Page 494 and 495:
Mancini test 479 marsupial immunity
- Page 496 and 497:
mast cell tryptase 481 Masugi nephr
- Page 498 and 499:
maturation of affinity 483 Mcg isot
- Page 500 and 501:
mediastinal mass 485 Mediterranean
- Page 502 and 503:
membrane attack unit 487 membrane c
- Page 504 and 505:
memory 489 mercury and immunity dis
- Page 506 and 507:
methyl green pyronin stain 491 MHC
- Page 508 and 509:
MHD 493 microglobulin Class II MHC
- Page 510 and 511:
microtiter technique 495 MIG The se
- Page 512 and 513:
Milstein, Cesar (1927-) 497 MIP-1β
- Page 514 and 515:
mitogen 499 Mitsuda reaction mitoch
- Page 516 and 517:
mixed lymphocyte reaction (MLR) 501
- Page 518 and 519:
molecular hybridization probe 503 m
- Page 520 and 521:
monoclonal immunoglobulin 505 monoc
- Page 522 and 523:
monoclonal immunoglobulin depositio
- Page 524 and 525:
monomorphic 509 mononuclear cell IC
- Page 526 and 527:
Montagu, Lady Mary Wortley (1689-17
- Page 528 and 529:
mucosal tolerance 513 multilocus pr
- Page 530 and 531:
multiple sclerosis (MS) 515 mumps v
- Page 532 and 533:
myc 517 mycophenolate mofetil and a
- Page 534 and 535:
myelin basic protein (MBP) 519 myel
- Page 536:
myogenin (F5D, mouse) 521 myositis-
- Page 539 and 540:
natural antiviral immunity 524 natu
- Page 541 and 542:
naturally acquired immunity 526 Nei
- Page 543 and 544:
nephelometry 528 network theory VLA
- Page 545 and 546:
neuron-specific enolase (NSE) 530 n
- Page 547 and 548:
New Zealand white (NZW) mice 532 ni
- Page 549 and 550:
NON mouse 534 nonproductive rearran
- Page 551 and 552:
northern blotting 536 nuclear facto
- Page 553 and 554:
Nuttall, George H.F. (1862-1937) 53
- Page 555 and 556:
OKT4 540 oncofetal antigens OKT4 Re
- Page 557 and 558:
ontogeny 542 oral immunology ontoge
- Page 559 and 560:
orthotopic 544 Ouchterlony test Don
- Page 561 and 562:
Ovary, Zoltan 546 Owen, Ray David (
- Page 563 and 564:
oxygen-independent killing 548 Oz i
- Page 565 and 566:
panel reactive antibody (PRA) test
- Page 567 and 568:
papain 552 papain +H 3 N +H 3 N NH
- Page 569 and 570:
paradoxical reaction 554 paraprotei
- Page 571 and 572:
paroxysmal cold hemoglobinuria (PCH
- Page 573 and 574:
passive immunization 558 Pasteur, L
- Page 575 and 576:
pathogenesis-related (PR) proteins
- Page 577 and 578:
pemphigus vulgaris 562 pemphigus vu
- Page 579 and 580:
pepsinogen antibodies 564 peptidogl
- Page 581 and 582:
peripheral lymphoid tissues 566 per
- Page 583 and 584:
pFc′ fragment 568 phagocyte Plate
- Page 585 and 586:
phagocytosis 570 phagocytosis polym
- Page 587 and 588:
phosphatase 572 phytohemagglutinin
- Page 589 and 590:
pituitary hormones 574 plaque-formi
- Page 591 and 592:
plasmacyte 576 plasma pool Plasma c
- Page 593 and 594:
platelet-associated immunoglobulin
- Page 595 and 596:
poison ivy 580 polyacrylamide gel e
- Page 597 and 598:
polyclonal rabbit anti-calretinin 5
- Page 599 and 600:
polynucleotides 584 positive cross
- Page 601 and 602:
post-transfusion graft-vs.-host dis
- Page 603 and 604:
precipitating antibody 588 precipit
- Page 605 and 606:
precipitation reaction 590 presento
- Page 607 and 608:
primary follicle 592 primary struct
- Page 609 and 610:
privileged site 594 progressive sys
- Page 611 and 612:
ProPO system 596 prostate-specific
- Page 613 and 614:
proteasome genes 598 protein P prot
- Page 615 and 616:
protoplast fusion 600 pseudoallergi
- Page 617 and 618:
psychoneuroimmunology 602 purified
- Page 619 and 620:
pyroglobulins 604 pyroninophilic ce
- Page 621 and 622:
Quellung phenomenon 606 quinidine (
- Page 623 and 624:
adiation bone marrow chimeras 608 r
- Page 625 and 626:
adiomimetic drug 610 Raji cell assa
- Page 627 and 628:
Ras 612 Raynaud’s phenomenon H 3C
- Page 629 and 630:
eagin (historical) 614 recombinant
- Page 631 and 632:
egional enteritis 616 relapsing pol
- Page 633 and 634:
escue graft 618 resting lymphocytes
- Page 635 and 636:
eticuloendothelial blockade 620 ret
- Page 637 and 638:
everse transcriptase-polymerase cha
- Page 639 and 640:
hesus incompatibility 624 rheumatoi
- Page 641 and 642:
hinovirus immunity 626 ricin rhinov
- Page 643 and 644:
RNA polymerase (RNAP) I, II, and II
- Page 645 and 646:
osette 630 Roux, Emile (1853-1933)
- Page 648 and 649:
S Abbreviation for sedimentation co
- Page 650 and 651:
Sanarelli-Shwartzman reaction 635 s
- Page 652 and 653:
SCF (stem cell factor) 637 schistos
- Page 654 and 655:
scurfy mouse 639 secondary granule
- Page 656 and 657:
secretor 641 secretory immunoglobul
- Page 658 and 659:
selective IgM deficiency 643 select
- Page 660 and 661:
sensitization 645 sequence-specific
- Page 662 and 663:
serotherapy 647 serum hepatitis (he
- Page 664 and 665:
sex hormones and immunity 649 Séza
- Page 666 and 667:
Shwartzman (or Shwartzman-Sanarelli
- Page 668 and 669:
side effect 653 autoantibodies (SRP
- Page 670 and 671:
single diffusion test 655 single ra
- Page 672 and 673:
skin autoantibodies 657 skin immuni
- Page 674 and 675:
slp 659 Smith, Theobald (1859-1934)
- Page 676 and 677:
SOD 661 soluble complex DD TRADD FA
- Page 678 and 679:
specific immune response to extrace
- Page 680 and 681:
spliceosomal snRNP autoantibodies 6
- Page 682 and 683:
SS-A/Ro antibodies 667 stem cells S
- Page 684 and 685:
streptolysin O test 669 Strongyloid
- Page 686 and 687:
superinfection immunity 671 suppres
- Page 688 and 689:
S value (Svedberg unit) 673 switch
- Page 690 and 691:
synthetic polypeptide antigens 675
- Page 692:
systemic lupus erythematosus, anima
- Page 695 and 696:
tail peptide 680 Tamiflu® Gaspare
- Page 697 and 698:
TATA 682 T cell antigen receptors c
- Page 699 and 700:
T cell domains 684 T cell priming c
- Page 701 and 702:
T cell receptor a chain (TCRa) 686
- Page 703 and 704:
template theory (historical) 688 te
- Page 705 and 706:
tertiary response 690 tetanus toxin
- Page 707 and 708:
Th1/Th2 differentiation 692 T h0 ce
- Page 709 and 710:
theliolymphocyte 694 thorotrast (th
- Page 711 and 712:
thymectomy 696 thymic hormones and
- Page 713 and 714:
thymopentin (TP-5) 698 thymus 1 32
- Page 715 and 716:
thymus 700 thymus Hassall’s corpu
- Page 717 and 718:
thymus-dependent (TD) areas 702 thy
- Page 719 and 720:
thyrotoxicosis 704 tissue-specific
- Page 721 and 722:
TLR1-10 706 T lymphocyte (T cell) A
- Page 723 and 724:
TNF-related activation-induced cyto
- Page 725 and 726:
topoisomerase I 710 toxin neutraliz
- Page 727 and 728:
TRALI (transfusion-related acute lu
- Page 729 and 730:
transfusion 714 transfusion reactio
- Page 731 and 732:
translocation 716 trastuzumab trans
- Page 733 and 734:
triple vaccine 718 tuberculin halo
- Page 735 and 736:
tumor-associated antigens 720 tumor
- Page 737 and 738:
tumor necrosis factor β (TNF-β) 7
- Page 739 and 740:
tunicates 724 type I anaphylactic h
- Page 741 and 742:
type 1 diabetes mellitus (T1DM) 726
- Page 743 and 744:
type IV cell-mediated hypersensitiv
- Page 746 and 747:
U antigen A rare MNs erythrocyte an
- Page 748 and 749:
unidentified reading frame (URF) 73
- Page 750 and 751:
V28 An orphan chemokine receptor ex
- Page 752 and 753:
varicella (chickenpox) vaccine 737
- Page 754 and 755:
V(D)J recombinase 739 veno-occlusiv
- Page 756 and 757:
V gene segment 741 Vibrio cholerae
- Page 758 and 759:
viral immunity 743 vitamin A and im
- Page 760 and 761:
V(J) recombination 745 von Krough e
- Page 762 and 763:
w Symbol for workshop used for hist
- Page 764 and 765:
Weibel-Palade bodies 749 wheal-and-
- Page 766 and 767:
wire loop lesion 751 Wright, Almrot
- Page 768 and 769:
X cell See XYZ cell theory. X4 viru
- Page 770:
X-linked severe combined immunodefi
- Page 774 and 775:
ZAP-70 A T cell cytoplasmic tyrosin
- Page 776:
Zinkernagel, Rolf (1944-) and Doher
- Page 779 and 780:
I Appendix I 764 Mouse CD Chart Ant
- Page 781 and 782:
I Appendix I 766 Mouse CD Chart Ant
- Page 783 and 784:
I Appendix I 768 Mouse CD Chart Ant
- Page 785 and 786:
I Appendix I 770 Mouse CD Chart Ant
- Page 787 and 788:
I Appendix I 772 Mouse CD Chart Ant
- Page 789 and 790:
I Appendix I 774 Mouse CD Chart Ant
- Page 791 and 792:
I Appendix I 776 Mouse CD Chart Ant
- Page 793 and 794:
I Appendix I 778 Mouse CD Chart Ant
- Page 796 and 797:
Appendix III Cytokines and Their Re
- Page 798:
Appendix III 783 Cytokines and Thei
- Page 801 and 802:
IV Appendix IV 786 Chemokines and T
- Page 803 and 804:
V Appendix V 788 Human Leukocyte Di
- Page 805 and 806:
V Appendix V 790 Human Leukocyte Di
- Page 807 and 808:
V Appendix V 792 Human Leukocyte Di
- Page 809 and 810:
V Appendix V 794 Human Leukocyte Di
- Page 811 and 812:
V Appendix V 796 Human Leukocyte Di
- Page 813 and 814:
V Appendix V 798 Human Leukocyte Di
- Page 815 and 816:
V Appendix V 800 Human Leukocyte Di
- Page 818 and 819:
Dr. Robert C. Khayat Chancellor, Un